HillCountryTimes - Market News: Edward Aldag, Chairman – President & CEO of Medical Properties Trust, Inc. (MPW) Just Unloaded Shares; Last Week NVIDIA (NVDA) Coverage

NVIDIA Corporation (NASDAQ:NVDA) Logo

NVIDIA Corporation (NASDAQ:NVDA) Ratings Coverage

Among 44 analysts covering Nvidia Corporation (NASDAQ:NVDA), 25 have Buy rating, 3 Sell and 16 Hold. Therefore 57% are positive. Nvidia Corporation had 189 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating given on Friday, November 6 by Morgan Stanley. RBC Capital Markets maintained the shares of NVDA in report on Friday, October 27 with “Buy” rating. Pacific Crest upgraded the shares of NVDA in report on Tuesday, June 20 to “Sector Weight” rating. The rating was downgraded by Instinet on Thursday, February 23 to “Reduce”. The rating was maintained by Pacific Crest with “Equal Weight” on Tuesday, August 4. RBC Capital Markets maintained it with “Buy” rating and $285.0 target in Wednesday, March 14 report. The rating was maintained by Needham with “Buy” on Friday, August 11. The rating was maintained by Mizuho with “Buy” on Thursday, November 9. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, June 21. The firm has “Hold” rating by Oppenheimer given on Thursday, August 10. See NVIDIA Corporation (NASDAQ:NVDA) latest ratings:

27/03/2018 Broker: SunTrust Rating: Buy Maintain
19/03/2018 Broker: FBR Capital Rating: Buy New Target: $290.0 Maintain
14/03/2018 Broker: RBC Capital Markets Rating: Buy New Target: $285.0 Maintain
07/03/2018 Broker: Rosenblatt Rating: Buy New Target: $300.0 Maintain
08/02/2018 Broker: Stifel Nicolaus Rating: Hold New Target: $220.0 Maintain
09/02/2018 Broker: B. Riley & Co Old Rating: Buy New Rating: Buy Old Target: $270 New Target: $290 Maintain
09/02/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $222 New Target: $258 Maintain
09/02/2018 Broker: SunTrust Rating: Buy New Target: $305.0 Maintain
09/02/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Hold Old Target: $205 New Target: $230 Maintain
09/02/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $240 New Target: $270 Maintain

Among 14 analysts covering Medical Properties Trust (NYSE:MPW), 5 have Buy rating, 1 Sell and 8 Hold. Therefore 36% are positive. Medical Properties Trust has $16 highest and $12.50 lowest target. $13.90’s average target is 6.92% above currents $13 stock price. Medical Properties Trust had 35 analyst reports since September 17, 2015 according to SRatingsIntel. Jefferies maintained the shares of MPW in report on Monday, August 28 with “Buy” rating. Deutsche Bank initiated the stock with “Buy” rating in Friday, July 22 report. On Thursday, June 22 the stock rating was maintained by Stifel Nicolaus with “Hold”. The firm has “Market Perform” rating given on Friday, July 1 by JMP Securities. The firm earned “Buy” rating on Tuesday, May 24 by Suntrust Robinson. Jefferies maintained the shares of MPW in report on Friday, June 9 with “Buy” rating. The rating was initiated by BTIG Research on Thursday, August 25 with “Neutral”. KeyBanc Capital Markets maintained Medical Properties Trust, Inc. (NYSE:MPW) on Monday, October 16 with “Hold” rating. As per Tuesday, November 21, the company rating was maintained by KeyBanc Capital Markets. SunTrust maintained Medical Properties Trust, Inc. (NYSE:MPW) rating on Thursday, November 2. SunTrust has “Buy” rating and $15.0 target.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. The company has market cap of $4.74 billion. MPT's financing model allows hospitals and other healthcare facilities to unlock the value of their underlying real estate in order to fund facility improvements, technology upgrades, staff additions and new construction. It has a 15.85 P/E ratio. Facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities.

Since February 14, 2018, it had 0 insider buys, and 1 sale for $6.07 million activity. 489,971 shares were sold by Aldag Edward K JR, worth $6.07M on Wednesday, February 14.

Analysts await Medical Properties Trust, Inc. (NYSE:MPW) to report earnings on May, 3. They expect $0.36 earnings per share, up 9.09% or $0.03 from last year’s $0.33 per share. MPW’s profit will be $131.12 million for 9.03 P/E if the $0.36 EPS becomes a reality. After $0.37 actual earnings per share reported by Medical Properties Trust, Inc. for the previous quarter, Wall Street now forecasts -2.70% negative EPS growth.

The stock increased 0.46% or $0.06 during the last trading session, reaching $13. About 2.95 million shares traded or 20.43% up from the average. Medical Properties Trust, Inc. (NYSE:MPW) has declined 1.18% since March 30, 2017 and is downtrending. It has underperformed by 12.73% the S&P500.

Investors sentiment is 1.23 in 2017 Q4. Its the same as in 2017Q3. It is the same, as 20 investors sold Medical Properties Trust, Inc. shares while 105 reduced holdings. only 47 funds opened positions while 107 raised stakes. 286.05 million shares or 1.77% less from 291.21 million shares in 2017Q3 were reported. Jpmorgan Chase And reported 0% stake. Qs Invsts Ltd Llc holds 14,900 shares. The Pennsylvania-based Janney Montgomery Scott Limited Co has invested 0.04% in Medical Properties Trust, Inc. (NYSE:MPW). Fifth Third Fincl Bank has invested 0% in Medical Properties Trust, Inc. (NYSE:MPW). Ftb Advsr stated it has 0% in Medical Properties Trust, Inc. (NYSE:MPW). Deutsche Commercial Bank Ag holds 0% or 336,965 shares. Lvm Capital Mi has invested 2.44% of its portfolio in Medical Properties Trust, Inc. (NYSE:MPW). Eii Cap Mgmt holds 0.29% of its portfolio in Medical Properties Trust, Inc. (NYSE:MPW) for 49,878 shares. California Public Employees Retirement System holds 928,163 shares. Nuveen Asset Limited Liability Company accumulated 0.11% or 1.21M shares. State Of Tennessee Treasury Department reported 170,000 shares stake. Walleye Trading Ltd Liability Com stated it has 1,131 shares. Tekla Cap Management Limited Liability Corp owns 858,586 shares. Vantage Invest Advisors Ltd Liability invested in 0.01% or 3,500 shares. Earnest Prns Lc accumulated 4.11 million shares.

Edward Aldag – an intelligent insider in Medical Properties Trust Inc who is the present Chairman – President & CEO — unloaded 116,216 shares of Medical Properties Trust Inc, that are worth about U.S Dollars 1,459,673 at an average price-per-share of U.S Dollars 12.6. Edward Aldag now indirectly holds 0 shares. He also directly holds 1759620 shares. In total he holds a stake of 0.48%.

The stock increased 4.63% or $10.24 during the last trading session, reaching $231.59. About 22.92 million shares traded or 51.73% up from the average. NVIDIA Corporation (NASDAQ:NVDA) has risen 108.33% since March 30, 2017 and is uptrending. It has outperformed by 96.78% the S&P500.

Investors sentiment decreased to 1.21 in Q4 2017. Its down 0.09, from 1.3 in 2017Q3. It turned negative, as 59 investors sold NVIDIA Corporation shares while 301 reduced holdings. 113 funds opened positions while 321 raised stakes. 363.65 million shares or 6.07% less from 387.15 million shares in 2017Q3 were reported. Ahl Prns Limited Liability Partnership holds 0.03% or 8,336 shares in its portfolio. Acg Wealth has 1.01% invested in NVIDIA Corporation (NASDAQ:NVDA) for 35,209 shares. Balasa Dinverno & Foltz Llc invested in 14,207 shares or 0.41% of the stock. Cap One National Association holds 4,653 shares. Css Ltd Liability Il has 0.16% invested in NVIDIA Corporation (NASDAQ:NVDA). Truenorth invested 1.09% in NVIDIA Corporation (NASDAQ:NVDA). Washington Bank & Trust has invested 0.19% of its portfolio in NVIDIA Corporation (NASDAQ:NVDA). Salem Investment Counselors Inc reported 0.26% in NVIDIA Corporation (NASDAQ:NVDA). Parus Fin (Uk) Ltd owns 263,695 shares. The Kentucky-based D Scott Neal has invested 0.03% in NVIDIA Corporation (NASDAQ:NVDA). Jaffetilchin Inv Ptnrs Ltd Liability Corp stated it has 0.19% in NVIDIA Corporation (NASDAQ:NVDA). Newman Dignan Sheerar holds 0.28% of its portfolio in NVIDIA Corporation (NASDAQ:NVDA) for 2,942 shares. Wealthfront Inc owns 0.05% invested in NVIDIA Corporation (NASDAQ:NVDA) for 23,284 shares. Hanson Mcclain owns 733 shares or 0.01% of their US portfolio. Brinker Cap Inc accumulated 0.06% or 7,548 shares.

Since October 2, 2017, it had 0 insider buys, and 8 insider sales for $26.32 million activity. Kress Colette also sold $4.23 million worth of NVIDIA Corporation (NASDAQ:NVDA) shares. $23,496 worth of NVIDIA Corporation (NASDAQ:NVDA) was sold by Byron Michael on Friday, March 2. Shoquist Debora sold $6.34M worth of stock or 33,498 shares. GAITHER JAMES C also sold $9.91 million worth of NVIDIA Corporation (NASDAQ:NVDA) on Thursday, February 15. PERRY MARK L sold $3.94 million worth of NVIDIA Corporation (NASDAQ:NVDA) on Monday, February 12. Drell Persis also sold $119,427 worth of NVIDIA Corporation (NASDAQ:NVDA) on Wednesday, December 20.

NVIDIA Corporation operates as a visual computing firm worldwide. The company has market cap of $140.11 billion. It operates in two divisions, GPU and Tegra Processor. It has a 48.05 P/E ratio. The GPU segment offers processors, which include GeForce for PC gaming; GeForce NOW for cloud game-streaming service; Quadro for design professionals working in computer-aided design, video editing, special effects, and other creative applications; Tesla for deep learning, accelerated computing, and general purpose computing; and GRID for cloud visual computing users.

Medical Properties Trust, Inc. (NYSE:MPW) Institutional Positions Chart